- World rank, all time
- #29,264 of 42,892
- Rank in United Kingdom
- #1,562 of 2,253
- Research works
- 123 ▼ 18% vs 2013–17
- Citations
- 6.3k 51.0 per fractional work
- Top-10% rate
- 9.4% record average 16.5%
- Open access
- 38% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 15.2×. Every wedge is a field page.
- Chemistry 15.2×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Immunology and Microbiology 1.7×
- Medicine 1.7×
- Computer Science 1.4×
- Pharmacology, Toxicology and Pharmaceutics 1.3×
- Environmental Science 1.1×
- Health Professions 0.8×
- Economics, Econometrics and Finance 0.7×
- Physics and Astronomy 0.4×
- Neuroscience 0.3×
- Engineering 0.2×
- Mathematics 0.1×
- Psychology 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Vertex Pharmaceuticals (United Kingdom)?
Ranked on the composite score, John R. Pollard lead among researchers whose main affiliation is Vertex Pharmaceuticals (United Kingdom).
- 1 John R. Pollard United Kingdom · #111,758 worldwide 791 citations · 21 works
Which keywords describe research at Vertex Pharmaceuticals (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Cancer, Apoptosis, Mutation, Drug Discovery, DNA Damage, Synthesis and Homologous Recombination.
- Peptide Synthesis
- Heterocycles
- Anticancer Agents
- G-Protein-Coupled Receptors
- Cell Death
- Macrocycles
- Signal Transduction
- Genetic Variation
- Microtubules
- Cell Signaling
- Transition Metal Catalysis
- Cystic Fibrosis
- p53
- Repair
- Regulation
- Chromatin
- Synthesis
- DNA Damage
- Drug Discovery
- Cancer
- Cancer Therapy
- Apoptosis
- Mutation
- Inflammation
- Homologous Recombination
- Tumor Suppression
- Genomic Instability
- Cell Cycle
- CFTR
- Medicinal Chemistry
- Biological Evaluation
- Cell Division
- Organic Synthesis
- Pharmacology
- C-C Bond Formation
- Tumor Microenvironment
- Crystal Structure
- Anticancer
- Foldamers
- Oxidation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Therapy15▲ 19×12 topics
- Cancer10▲ 5.8×14 topics
- Apoptosis8▲ 16×8 topics
- Drug Discovery7▲ 15×7 topics
- Mutation7▲ 38×4 topics
- DNA Damage7▲ 41×4 topics
- Inflammation7▲ 2.3×24 topics
- Synthesis7▲ 9.3×10 topics
- Homologous Recombination6▲ 73×2 topics
- Chromatin5▲ 48×2 topics
- Tumor Suppression5▲ 38×2 topics
- Regulation5▲ 7.1×2 topics
- Genomic Instability5▲ 33×1 topic
- Repair5▲ 82×1 topic
- Cell Cycle5▲ 70×1 topic
- p535▲ 93×1 topic
- CFTR5▲ 147×1 topic
- Cystic Fibrosis5▲ 49×1 topic
- Medicinal Chemistry5▲ 11×5 topics
- Transition Metal Catalysis5▲ 28×3 topics
- Biological Evaluation4▲ 26×4 topics
- Cell Signaling4▲ 9.1×6 topics
- Cell Division4▲ 78×1 topic
- Microtubules4▲ 78×1 topic
- Organic Synthesis4▲ 13×7 topics
- Genetic Variation3▲ 8.7×5 topics
- Pharmacology3▲ 8.2×4 topics
- Signal Transduction3▲ 11×3 topics
- C-C Bond Formation3▲ 26×2 topics
- Macrocycles3▲ 25×2 topics
- Tumor Microenvironment3▲ 6.8×5 topics
- Cell Death3▲ 11×4 topics
- Crystal Structure3▲ 9.3×1 topic
- G-Protein-Coupled Receptors3▲ 29×1 topic
- Anticancer3▲ 11×4 topics
- Anticancer Agents3▲ 8.5×3 topics
- Foldamers2▲ 25×1 topic
- Heterocycles2▲ 11×3 topics
- Oxidation2▲ 9.6×2 topics
- Peptide Synthesis2▲ 25×1 topic
Which research topics does Vertex Pharmaceuticals (United Kingdom) publish most on?
By volume in 2022–2025: Cystic Fibrosis Research Advances, Cannabis and Cannabinoid Research, Chemistry and Chemical Engineering and Security and Verification in Computing.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 2 works
- 2 Cannabis and Cannabinoid Research Pharmacology 1 works
- 3 Chemistry and Chemical Engineering Environmental Chemistry 1 works
- 4 Security and Verification in Computing Artificial Intelligence 1 works
- 5 Cloud Data Security Solutions Information Systems 1 works
- 6 Asymmetric Synthesis and Catalysis Organic Chemistry 1 works
- 7 History and advancements in chemistry Physical and Theoretical Chemistry 1 works
- 8 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
- 9 Radical Photochemical Reactions Organic Chemistry 0 works
- 10 Chemical synthesis and alkaloids Organic Chemistry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Vertex Pharmaceuticals (United Kingdom)'s research output changed?
Output in 2018–2022 was 18% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in London
- University College London
- Imperial College London
- King's College London
- Queen Mary University of London
- London School of Economics and Political Science
- University of London
- Brunel University of London
- London School of Hygiene & Tropical Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.